Safety studies on intravenous infusion of a potent angiogenesis inhibitor: taurocholate-conjugated low molecular weight heparin derivative LHT7 in preclinical models

Author:

Alam Farzana1,Hwang Seung Rim2,Al-Hilal Taslim A.3,Chung Seung Woo1,Kim Hak-Soo4,Kang Boo-Hyun4,Zhang Hu-Song4,Shin Seo-Ho4,Lee Joo-Young4,Kang Min-Soo4,Kwon Geum-Hee4,Jeon Ok-Cheol5,Kim Sang Yoon67,Byun Youngro15

Affiliation:

1. Research Institute of Pharmaceutical Science, College of Pharmacy, Seoul National University, Seoul, South Korea;

2. College of Pharmacy, Chosun University, Gwangju, South Korea;

3. Center for Theragonosis, Biomedical Research Institute, Korea Institute of Science and Technology, Wolgog, Seoul, South Korea;

4. ChemOn Inc., Bio-Research Center, Gyeonggi-Do, South Korea;

5. Mediplex Corp, Seoul, South Korea;

6. Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, South Korea;

7. Department of Otolaryngology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3